Furthermore, by indirectly regulating the Bcl-2, Nrf2 inhibited the BAD protein expression through the PI3K-AKT signalling pathway, resulting in drug resistance in B-ALL cells. This evidence concerns the gene BCL2 and acute lymphoblastic leukemia.